What are the Side Effects of CBD Oil?

The relationship between infection and conventional antibiotics

Could new earth CBD be useful in the fight versus resistant bacterial stress? The arise from the University of Queensland in Australia suggest that it is possible. However before taking a look at the study in depth, it works to comprehend the development of the relationship between germs and antibiotics.

Because the advanced discovery of penicillin by Alexander Fleming in 1928, antibiotics have actually been a vital tool in the fight versus germs and infections. And although we still use the same tested methods today, germs have actually progressed. When exposed to antibiotics, particular germs, fungi and parasites are able to adapt and cancel the efficiency of the drug by establishing resistance.

It’s worth mentioning that antimicrobial resistance was likely to take place anyway, as the hereditary code for germs modifications with time. Nevertheless, it is thought that the overuse of antibiotics is a crucial factor that speeds up the advancement of resistant stress.

According to the World Health Organization, antimicrobial resistance “is an increasingly serious risk to global public health that requires action in all sectors of federal government and in society.” This has led researchers to think outside the box by trying to identify compounds that could be beneficial in the fight versus harmful germs. One of these compounds is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Researchers are searching for new methods to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective versus Gram-positive germs. Strains of Gram-positive germs include Staphylococcus aureus (typical in skin infections) and Streptococcus pneumoniae (typical in bacterial pneumonia).

Dr. Blaskovich provided his findings at an annual meeting of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with synthetic CBD resource. The results led Dr. Blaskovich to the conclusion that CBD works at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive stress of resistant germs, which many traditional antibiotics are starting to stop working.

” In particular, the activity was selected versus the resistant stress of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to cause resistance and was active versus MRSA biofilms. “

The group also performed another study using topical CBD to deal with a skin infection in mice. Again, although the results were positive, CBD did not appear to get rid of the infection, but simply to reduce the number of bacterial cells.

Could CBD become an antibiotic?

While it is simple to hail this work as a substantial breakthrough in the anti-bacterial capabilities of CBD, it is too soon to quit on penicillin.

Although it is thought that the efficiency of CBD could come from the method it attacks the biofilm surrounding bacterial cells, the authors are still unsure of the system of action of CBD. They also did not hesitate to point out the shortcomings of the study. Dr. Blaskovich pointed out that because the results are in the initial phases, it is far too early for people to start treating their CBD infections themselves.

The study was also performed in vitro (outside the human body), and there is a danger that the results of clinical trials will not be the same. Numerous compounds have actually shown anti-bacterial efficacy in petri dishes, but then failed at this vital phase. It ought to also be pointed out that the two studies were performed in partnership with Botanix Pharmaceuticals Ltd, a pharmaceutical company specializing in topical CBD products.

Nevertheless, this research could be a crucial advance for CBD and the fight versus antimicrobial resistance. CBD continues to have a good security profile and is not considered poisonous even in big amounts. Thankfully, Dr. Blaskovich and his group strategy to continue their research.

Scroll to top